Product Information
LAMOTRIGINE ER 25 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.2751 per EA under NDC 16714062301. Its NADAC has been published 465 times since Nov 8, 2017.
FDA first approved this application on Jun 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714062301
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA202383FDA Approved
6/19/2013
TE Code
AB
On Market Since
6/20/2017
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ER 25 MG TABLET has been published 465 times since Nov 8, 2017, and over the history we have for it it has declined 90.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2751 per EA |
|---|---|
| All-time high | $3.0286 (Feb 14, 2018) |
| All-time low | $0.2224 (Nov 20, 2024) |
| 52-week high | $0.4670 |
| 52-week low | $0.2421 |
| Median price | $0.9960 |
| Average price | $1.1279 |
| Largest weekly change | +90.5% (Dec 18, 2024) |
| Weeks tracked | 465 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ER 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 25 MG TABLET, manufactured by NorthStar Rx LLC, is $0.2751 per EA (NDC 16714062301), effective Sep 30, 2026.
How has the price of LAMOTRIGINE ER 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ER 25 MG TABLET has declined 90.9%. It has been tracked across 465 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 25 MG TABLET?
Since Nov 8, 2017, the NADAC for LAMOTRIGINE ER 25 MG TABLET has ranged from a low of $0.2224 (Nov 20, 2024) to a high of $3.0286 (Feb 14, 2018), with a median of $0.9960 per EA.
Are there cheaper alternatives to LAMOTRIGINE ER 25 MG TABLET?
Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 25 MG TABLET, is $0.0268 per EA — about 90% below LAMOTRIGINE ER 25 MG TABLET.
Who manufactures LAMOTRIGINE ER 25 MG TABLET?
LAMOTRIGINE ER 25 MG TABLET (NDC 16714062301) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.